Source: International Congress 2019 – New molecular signatures in COPD, lung cancer and a1-antitrypsin deficiency
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Gotera (Madrid, Spain), A. Pereira Vega (Huelva, Spain), T. García Barrera (Huelva, Spain), J. Marín Trigo (Zaragoza, Spain), C. Casanova Macario (Santa Cruz de Tenerife, Spain), B. García-Cosío Piqueras (Palma de Mallorca, Spain), I. Mir Viladrich (Palma de Mallorca, Spain), I. Solanes García (Barcelona, Spain), J. Gómez Ariza (Huelva, Spain), J. López Campos (Sevilla, Spain), L. Seijo Maceiras (Madrid, Spain), N. Feu Collado (Cordoba, Spain), C. Cabrera Lopez (Las Palmas de Gran Canarias, Spain), R. Agüero Balbin (Santander, Spain), A. Romero Plaza (Islas Baleares, Spain), J. De Torres Tajes (Pamplona, Spain), L. Padrón Fraysse (Huelva, Spain), B. Callejón Leblic (Huelva, Spain), E. Márquez Martín (Sevilla, Spain), M. Marín Royo (Castellón, Spain), E. Balcells Vilarnau (Barcelona, Spain), A. Llunel Casanova (Barcelona, Spain), C. Martínez González (Oviedo, Spain), J. Galdiz Iturri (Baracaldo, Spain), C. Lacárcel Bautista (Jaén, Spain), G. Peces-Barba (Madrid, Spain). Metabolomic analysis of severe COPD. Study of biomarkers in the CHAIN cohort.. 4049

Member's Comments

No comment yet.

Related content which might interest you: Identification and analysis of clinical phenotypes in COPD patients: PALOMB Cohort Source: Virtual Congress 2021 – COPD burden, epidemiology and management Year: 2021 Plasma metabolomic signature in COPD patients: Associations to proteomic profile and clinical outcomes Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Unbiased clinical cluster analysis of patients of ProAR Asthma Cohort. Source: International Congress 2018 – New modalities in asthma treatment Year: 2018 Altered serum metabolomics in COPD: analysis of the SPIROMICS cohort Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond Year: 2018 Parametric response mapping of COPD phenotypes: A COPDGene study Source: International Congress 2015 – CT, PET, MRI modalities: fusion of anatomical and functional variables for lung assessment Year: 2015 Persistence of clinical criteria of chronic bronchitis in patients with COPD over time: A longitudinal analysis of the TRACE cohort. Source: International Congress 2017 – Markers of COPD progression Year: 2017 Health status predicts long-term outcomes in patients with chronic obstructive pulmonary disease (COPD): Pooled analysis of patient-level data from the COPD biomarker qualification consortium database Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015 Longitudinal validation of clinical COPD phenotypes identified by cluster analysis Source: Annual Congress 2011 - COPD diagnosis Year: 2011 Phenotypes, treatable traits, GOLD groups and grades – how they predict mortality risk in COPD patients? (data from the Czech Multicenter Research Database of COPD) Source: Virtual Congress 2020 – New tools for risk stratification of obstructive diseases Year: 2020 Proteomics analysis of asthma biomarkers: proxima sub-study Source: International Congress 2017 – Novel mechanisms in asthma Year: 2017 Mortality risk prediction in COPD by a prognostic biomarker panel – Results of a derivation and validation cohort with a long term follow-up Source: International Congress 2014 – Markers Year: 2014 Measuring exacerbations in subjects with mild to moderate COPD from a population-based cohort: The CanCOLD study Source: Annual Congress 2013 –Factors associated with outcomes in COPD Year: 2013 Cluster analysis on longitudinal data of patients with adult-onset asthma Source: International Congress 2016 – Asthma: from basic mechanisms to novel therapeutic perspectives Year: 2016 Risk of future exacerbations among COPD patients – a real-world register-based cohort study (AvoidEx) Source: Virtual Congress 2020 – Airflow obstruction, COPD and comorbidities Year: 2020 Characteristics of subjects susceptible to exacerbation-like respiratory events in a population-based cohort: Canadian cohort obstructive lung disease (CanCOLD) study Source: International Congress 2014 – Longitudinal studies of respiratory disease Year: 2014 Observational study to characterise 24-hour COPD symptoms: Interim analysis of ASSESS Source: Annual Congress 2013 –Monitoring symptoms and quality of life Year: 2013 Late Breaking Abstract - Analysis of the InforMing the PAthway of COPD Treatment (IMPACT) study in the subgroup of patients taking triple therapy at screening Source: International Congress 2018 – COPD: from LABA/ICS to LABA/LAMA/ICS Year: 2018 Distribution and significance of GOLD 2011 disease severity classification in patients with COPD in China: A national cross-sectional survey Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013 Mortality and exacerbation prediction by GOLD groups ABCD 2011 vs. 2017: analysis of the COPDGene cohort Source: International Congress 2017 – COPD management: new findings from large studies Year: 2017 The characteristics of ACOS in a population based asthma cohort Source: International Congress 2016 – COPD and asthma COPD overlap syndrome (ACOS): novelties in terms of prevalence, risk factors, and prognosis in COPD Year: 2016